Who is sponsoring NCT04686318?

NCT04686318 is sponsored by University of Southern Denmark.

What drugs are being tested in NCT04686318?

Interventions in NCT04686318: Biomarkers for acute pyelonephritis.

What condition does NCT04686318 study?

NCT04686318 studies Acute Pyelonephritis.

Is NCT04686318 still recruiting?

NCT04686318 is currently completed. Last updated 14 September 2022.

Last reviewed 2022-09-14 · How we verify

NCT04686318

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Accuracy of Infection Biomarkers in the Investigation of Patients With Suspected Acute Pyelonephritis

Completed Last updated 14 September 2022

What this trial tests

trial testing Biomarkers for acute pyelonephritis in Acute Pyelonephritis in 229 participants. Completed in 1 June 2022.

Timeline

1 March 2021

Primary endpoint
28 February 2022

1 June 2022

Quick facts

Lead sponsor	University of Southern Denmark
Status	Completed
Study type	OBSERVATIONAL
Enrollment	229
Start date	1 March 2021
Primary completion	28 February 2022
Estimated completion	1 June 2022
Sites	1 location across Denmark

Drugs / interventions tested

Biomarkers for acute pyelonephritis

Conditions studied

Acute Pyelonephritis — all drugs for Acute Pyelonephritis →

Sponsor

University of Southern Denmark

Who can join

18 and older, any sex, with Acute Pyelonephritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the diagnostic and prognostic value of C-reactive protein (CRP), serum procalcitonin (PCT) and soluble urokinase plasminogen activator receptor (suPAR) in the initial investigation of patients hospitalized with suspected acute pyelonephritis (APN).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Improved diagnostics of infectious diseases in emergency departments: a protocol of a multifaceted multicentre diagnostic study.
Skjøt-Arkil H, Heltborg A, Lorentzen MH, Cartuliares MB, et al · · 2021 · cited 17× · PMID 34593497 · DOI 10.1136/bmjopen-2021-049606
Prediction of infection in the emergency department-a machine learning model.
Søgaard SN, Skjøt-Arkil H, Mogensen CB, Rosenvinge FS, et al · · 2026 · PMID 42147041 · DOI 10.3389/frai.2026.1812692

Verify or expand the search:

Other University of Southern Denmark trials

Trials by the same sponsor.

NCT07531290 — PeerScreen Trial - Reducing Screen Media Use in Peer-groups of Young People · NA · not yet recruiting
NCT07384273 — Evaluating the Effectiveness of an Internet-based Therapy (iCARE) to Treat Symptoms of Postpartum Depression · NA · recruiting
NCT07426679 — Should Anaesthesiologists Be Taught to Perform Ultrasound-- Assisted Neuraxial Access in Spinal Anaesthesia? · NA · recruiting
NCT07104292 — Pelvic Floor Muscle Training During Pregnancy · NA · recruiting
NCT07194759 — Health Literacy Levels of Patients Living With Type 2 Diabetes and Multi-disease and Their Families Using HLQTM · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04686318 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Southern Denmark
Last refreshed: 14 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04686318.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing